GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » Additional Paid-In Capital

DOD Biotech PCL (BKK:DOD-R) Additional Paid-In Capital : ฿947.3 Mil(As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Additional Paid-In Capital?


DOD Biotech PCL's quarterly additional paid-in capital declined from Sep. 2024 (฿947.3 Mil) to Dec. 2024 (฿947.3 Mil) but then stayed the same from Dec. 2024 (฿947.3 Mil) to Mar. 2025 (฿947.3 Mil).

DOD Biotech PCL's annual additional paid-in capital increased from Dec. 2022 (฿890.8 Mil) to Dec. 2023 (฿1,050.5 Mil) but then declined from Dec. 2023 (฿1,050.5 Mil) to Dec. 2024 (฿947.3 Mil).

DOD Biotech PCL Additional Paid-In Capital Historical Data

The historical data trend for DOD Biotech PCL's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Additional Paid-In Capital Chart

DOD Biotech PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 939.87 890.85 890.85 1,050.54 947.27

DOD Biotech PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,050.54 947.27 947.27 947.27 947.27

DOD Biotech PCL Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

DOD Biotech PCL Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » Additional Paid-In Capital
Comparable Companies
BKK:CFRESH BKK:BIS BKK:CM BKK:JSP BKK:SST BKK:GLOCON BKK:CHOTI BKK:NRF BKK:APO BKK:VPO XSWX:NESN XPAR:BN JBS SHSE:603288 KHC NSE:NESTLEIND K GIS TSE:2802 SHSE:600887
Traded in Other Exchanges
DOD:Thailand
Address
No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
Website
https://www.dodbiotech.com
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines